Pivotal study to determine the impact of Perimeter’s novel OCT imaging technology combined with artificial intelligence on positive margin rates for patients with breast cancer TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging A
Significant progress achieved for lead investigational drug candidate uproleselan: Robust enrollment momentum in the quarter indicates imminent completion of enrollment for Company-sponsored Phase 3 pivotal trial in patients with relapsed/refractory a
Breakthrough pre-clinical, research findings to be released show therapeutic advancements on the data-driven evolution of psychedelic psilocybin molecule TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Gensource Potash Corporation ("Gensource" or the "Company") (TSX.V: GSP), a fertilizer development company focused on sustainable potash production, advises that, in reference to the Company’s news releases date
YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that the European Medicines Agency (EMA) granted orphan drug designation (ODD) to Hunterase ICV (intracerebroventricular, generic name: idursulfase-beta (recombinant)) for the tre
All amounts are in US dollars except as otherwise noted SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today its third quarter 2021 results, with net earnings of $726 million ($1.25 diluted earnings per share). Third
icIEF-MS accelerates biotherapeutic development through identification of charge variants at the intact protein level FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, builds a new category of analytical
WINNIPEG, Manitoba--(BUSINESS WIRE)--$FDGE--Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE) announced today that the Company’s third quarter 2021 financial results will be released after market close on Thursday, November 11, 202
- Longest available outcomes data with LUPKYNIS will be presented virtually during American College of Rheumatology (ACR) Convergence 2021; final results expected by the end of 2021 – - Updated interim analysis shows sustained safety and tolerability
FOUNTAIN VALLEY, Calif. & VANCOUVER, British Columbia--(BUSINESS WIRE)--Lab Genomics, a personalized medicine company providing state of the art molecular genetic testing in Southern California and other US locations, today announced in partnership with C
Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.
With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate
ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.